Search

everythinglearnresearchcommunity

for

Search:↓

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Hair loss gene linked to prostate issues.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Higher cholesterol levels increase aggressive prostate cancer risk.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.